Clinical Trials Browser

Phase 2 × Pancreatic Adenocarcinoma Metastatic × 1 year × Clear all

NCT06747845 2025-09-16

ParpVax2

Phase 2 Recruiting

Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

NCT05360264 2025-03-24

ORIENTATE

Phase 2 Terminated

Gastrointestinal

Pancreatic Adenocarcinoma Metastatic